SCHEMBL9764536

SCHEMBL9764536

CC(=O)Nc1ccc(CCOCCCCCCNCc2ccccc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN8A Q9UQD0 1/20 0.57
PTPN1 P18031 1/20 0.52
SIGMAR1 Q99720 3/20 0.49
BCHE P06276 4/20 0.48
ACHE P22303 2/20 0.48
MAOA P21397 1/20 0.47
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
ALDH1A1 P00352 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
KDM4E B2RXH2 2/20 0.46
MAPK1 P28482 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CHRM2 P08172 1/20 0.46
ATM Q13315 1/20 0.45
HDAC3 O15379 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
NCOR2 Q9Y618 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9763358 0.91 SIGMAR1 (0.51) SCN8ASIGMAR1BCHEACHEMAOA
SCHEMBL9763151 0.89 BCHE (0.49) SCN8ASIGMAR1BCHEACHEMAOA
SCHEMBL9762664 0.88 SIGMAR1 (0.49) SCN8ASIGMAR1BCHEACHEMAOA
SCHEMBL9763305 0.88 BCHE (0.46) SCN8ASIGMAR1BCHEACHEMAOA
SCHEMBL9762667 0.87 SLC2A1 (0.50) SIGMAR1BCHEACHEMAOAKMT2A
SCHEMBL9762652 0.86 POLB (0.51) ALDH1A1MAPK1L3MBTL1ATMHDAC3
SCHEMBL9764394 0.83 SIGMAR1 (0.69) SIGMAR1BCHEMAOAKMT2AMEN1
SCHEMBL10477755 0.83 SIGMAR1 (0.69) SIGMAR1BCHEMAOAKMT2AMEN1
SCHEMBL9762676 0.83 SIGMAR1 (0.52) SIGMAR1BCHEACHEKMT2A
SCHEMBL9763666 0.83 MAOA (0.46) SCN8ASIGMAR1BCHEACHEMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5006556-A Dichloroaniline derivatives for the therapy or prophylaxysis of a disease associated with reversible airway obstruction GLAXO GROUP LIMITED (GB) 1991-04-09 US disclosed
US-4943591-A TREATMENT OF ASTHMA AND BRONCHITIS GLAXO GROUP LIMITED (GB) 1990-07-24 US disclosed
EP-0181709-B1 DICHLOROANILINE DERIVATIVES GLAXO GROUP LIMITED (GB) 1990-05-09 EP disclosed
US-4908386-A Pharmaceuticals GLAXO GROUP LIMITED (GB) 1990-03-13 US disclosed
EP-0220054-A2 Ethanolamine derivatives GLAXO GROUP LIMITED (GB) 1987-04-29 EP disclosed
EP-0181709-A1 Dichloroaniline Derivatives GLAXO GROUP LIMITED (GB) 1986-05-21 EP disclosed